This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Compass Point analyst Casey Alexander downgraded the rating for PennantPark Investment Corporation (NYSE:PNNT) from Neutral to Sell and lowered the price target from $6 to $5.75. Pennant Park Investment shares closed at $6.91 on Tuesday. See how other analysts view this stock.
• HSBC analyst Sidharth Sahoo downgraded UnitedHealth Group Incorporated (NYSE:UNH) from Hold to Reduce and lowered the price target from $490 to $270. UnitedHealth shares closed at $321.58 on Tuesday. See how other analysts view this stock.
• Scotiabank analyst Sung Ji Nam downgraded the rating for Myriad Genetics, Inc. (NASDAQ:MYGN) from Sector Outperform to Sector Perform and cut the price target from $20 to $6. Myriad Genetics shares closed at $4.45 on Tuesday. See how other analysts view this stock.

Considering buying UNH stock? Here’s what analysts think:

Read This Next:

• Target, Lowe’s And 3 Stocks To Watch Heading Into Wednesday

Photo via Shutterstock